Telix Pharmaceuticals (TLX) Retained Earnings (2023 - 2025)
Telix Pharmaceuticals (TLX) reported Retained Earnings of $101.6 million for Q4 2025, down 2.11% year-over-year from $103.8 million in Q4 2024, and down 2.11% quarter-over-quarter from $103.8 million in Q4 2024.
Telix Pharmaceuticals (TLX) Retained Earnings (2023 - 2025) Analysis & Trends
Telix Pharmaceuticals (TLX) has 3 years of Retained Earnings data on file, last reported at $101.6 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at $101.6 million, down 2.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $101.6 million (down 2.11% YoY), and the FY2025 annual result was $101.6 million, up 166.42% from the prior year.
- Retained Earnings fell to $101.6 million in Q4 2025 per TLX's latest filing, from $103.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $103.8 million in Q4 2024 and troughed at -$171.6 million in Q4 2023.
- A 3-year average of $11.2 million and a median of $101.6 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings jumped 160.45% in 2024, then decreased 2.11% in 2025.
- A 3-year view of Retained Earnings shows it stood at -$171.6 million in 2023, then jumped by 160.45% to $103.8 million in 2024, then retreated by 2.11% to $101.6 million in 2025.
- Business Quant data shows TLX's Retained Earnings at $101.6 million in Q4 2025, $103.8 million in Q4 2024, and -$171.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Telix Pharmaceuticals | 4.56 Bn | 4.42 Bn | - | 101.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.56 Mn |
| Dec 31, 2024 | 103.75 Mn |
| Dec 31, 2023 | -171.64 Mn |